Victor S Issa
Overview
Explore the profile of Victor S Issa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcondes-Braga F, Gioli-Pereira L, Bernardez-Pereira S, Batista G, Mangini S, Issa V, et al.
ESC Heart Fail
. 2020 May;
7(4):1744-1752.
PMID: 32383349
Aims: Exhaled breath acetone (EBA) has been described as a new biomarker of heart failure (HF) diagnosis. EBA concentration increases according to severity of HF and is associated with poor...
2.
Rigaud V, Ferreira L, Ayub-Ferreira S, Avila M, Brandao S, Cruz F, et al.
Oncotarget
. 2017 Jan;
8(4):6994-7002.
PMID: 28052002
Cardiotoxicity is associated with the chronic use of doxorubicin leading to cardiomyopathy and heart failure. Identification of cardiotoxicity-specific miRNA biomarkers could provide clinicians with a valuable prognostic tool. The aim...
3.
Marcondes-Braga F, Batista G, Gutz I, Saldiva P, Mangini S, Issa V, et al.
PLoS One
. 2016 Dec;
11(12):e0168790.
PMID: 28030609
Background: The identification of new biomarkers of heart failure (HF) could help in its treatment. Previously, our group studied 89 patients with HF and showed that exhaled breath acetone (EBA)...
4.
Ayub-Ferreira S, Mangini S, Issa V, Cruz F, Bacal F, Guimaraes G, et al.
PLoS Negl Trop Dis
. 2013 May;
7(4):e2176.
PMID: 23638197
Background: Sudden death has been considered the main cause of death in patients with Chagas heart disease. Nevertheless, this information comes from a period before the introduction of drugs that...
5.
Marcondes-Braga F, Gutz I, Batista G, Saldiva P, Ayub-Ferreira S, Issa V, et al.
Chest
. 2012 Feb;
142(2):457-466.
PMID: 22345382
Background: Heart failure (HF) is associated with poor prognosis, and the identification of biomarkers of its severity could help in its treatment. In a pilot study, we observed high levels...
6.
Issa V, Andrade L, Ayub-Ferreira S, Bacal F, de Braganca A, Guimaraes G, et al.
Int J Cardiol
. 2012 Jan;
167(1):34-40.
PMID: 22243938
Background: Renal dysfunction is associated with increased mortality in patients with decompensated heart failure. However, interventions targeted to prevention in this setting have been disappointing. We investigated the effects of...
7.
Issa V, Amaral A, Cruz F, Ayub-Ferreira S, Guimaraes G, Chizzola P, et al.
Am Heart J
. 2010 Jan;
159(1):90-7.
PMID: 20102872
Background: Heart failure and diabetes often occur simultaneously in patients, but the prognostic value of glycemia in chronic heart failure is debatable. We evaluated the role of glycemia on prognosis...
8.
Issa V, Amaral A, Cruz F, Ferreira S, Guimaraes G, Chizzola P, et al.
Circ Heart Fail
. 2009 Nov;
3(1):82-8.
PMID: 19933408
Background: Peculiar aspects of Chagas cardiomyopathy raise concerns about efficacy and safety of sympathetic blockade. We studied the influence of beta-blockers in patients with Chagas cardiomyopathy. Methods And Results: We...
9.
Mocelin A, Issa V, Bacal F, Guimaraes G, Cunha E, Bocchi E
Eur J Heart Fail
. 2005 Jul;
7(5):869-73.
PMID: 16043406
Patients with Chagas' cardiomyopathy have the worst prognosis when compared to other aetiologies. It has been suggested that a more intense inflammatory activation could be responsible for this excessive mortality....